Reutericyclin and related analogues kill stationary phase Clostridium difficile at achievable colonic concentrations

Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections

(2010) Julian G. Hurdle et al.   NATURE REVIEWS MICROBIOLOGY

Evaluation of Analogs of Reutericyclin as Prospective Candidates for Treatment of Staphylococcal Skin Infections

(2009) J. G. Hurdle et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Distinctive Profiles of Infection and Pathology in Hamsters Infected with Clostridium difficile Strains 630 and B1

(2009) D. Goulding et al.   INFECTION AND IMMUNITY

Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model

(2009) U. A. Ochsner et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells

(2009) Shumei Zhai et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

The Case for Vancomycin as the Preferred Drug for Treatment ofClostridium difficileInfection

(2008) John G. Bartlett   CLINICAL INFECTIOUS DISEASES

N-Substituted 3-Acetyltetramic Acid Derivatives as Antibacterial Agents

(2008) Raghunandan Yendapally et al.   JOURNAL OF MEDICINAL CHEMISTRY